ABSTRACT
used in this study (6 experimental, 1 control), each group containing 5 animals. In each rat, two full thickness cranial defects we re developed (4mm in diameter), one on each hemicranium, produced with a dental burr while rinsing with a sterile lactated Ringer's solution to clear any remaining debris, and filled with either an implant material (experimental groups) or left empty (in control group), thus totaling 10 implant sites per group. The implant materials were 1) Bio-Oss , 2) Bioplant HTR, 3) Biogran, 4) Orthomatrix-HA, 5) Interpore 200 and 6) Pro-Osteon 500R. 2 animals per group were sacrificed after a 2-month healing period yielding 4 implant sites. One implant site was used for histological assessment for comparison with the 4 month healing groups. 3 implant sites were used for biochemical analysis (Alkaline phosphatase activity). 3 animals per group were sacrificed after a 4 months healing period yielding 6 implant sites. These implant sites were used for histomorphometric analysis.
Results
Since we were using less than the critical defect (8mm in diameter), our 4mm model would spontaneously attempt to heal. This provi des two -fold advantage in our experimental design:-1) is to assess if the FDA approved material enhances the new bone formation and healing, and 2) retard or delay the healing process relative to the untreated controls. Histomorphometric analysis showed that Bio-Oss and Orthomatrix-HA had the largest amount of bone formation compared to other experimental groups and controls, which was statistically significant (p< 0.05). Bio-Oss had the largest new bone formation followed by Bioplant HTR, Orthomatrix HA, and all were statistically different (p<0.05) from the control group. Interpore 200, Biogran and Pro-Osteon 500R were similar to or worse than that of the control group in promoting healing over a 4 month period using a 4mm defect.
Below is shown the histology of central portion of calvarial defects after 4 months healing. Control with no implant (left) and experimental with Bio-Oss implant (right).
Central portion control, 100x mag. Central portion Bio-Oss, 100xmag
Discussion/Conclusions
Our study indicated that Bio-Oss (de-organified bovine bone) and an Orthomatrix HA (synthetic hydroxyapatite ceramic) showed the most significant ability to promote bridging of a 4 mm defect over a 4 month healing period which resulted in superior healing of the defect. Bioplant HTR (biocompatible composite polymer) and, Interpore 200 (naturally-derived hydroxyapatite ceramics) were also capable of promoting bone growth and incorporating with the new bone, however to a lesser degree than the above 2 materials but nonetheless, better than the control. Significant and consistent amounts of bone growth occurred from the defect edges in all groups.
From this study we conclude that Bio-Oss, Orthomatrix HA and Bioplant HTR provide the best results in terms of healing enhancement and one could recommend for use in augmenting bone healing. Whereas Biogran, Interpore 200 and Pro-Osteon 500R appear not to offer any advantage, if anything they may be hindering healing.
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